Acute serious thrombocytopenia associated with intracoronary tirofiban use for primary angioplasty.
Mustafa YurtdaşYalin Tolga YaylaliNesim AladağMahmut OzdemirMemiş Hilmi AtayPublished in: Case reports in medicine (2014)
Tirofiban, a specific glycoprotein IIb/IIIa inhibitor, may cause extensive thrombocytopenia with an incidence of 0.2% to 0.5%. We report the case of a 50-year-old man who developed thrombocytopenia after tirofiban use (both intracoronary and peripheral) over hours and the successful management of this complication after primary percutaneous coronary intervention for acute ST-segment elevation myocardial infarction.
Keyphrases
- st segment elevation myocardial infarction
- percutaneous coronary intervention
- st elevation myocardial infarction
- liver failure
- acute coronary syndrome
- acute myocardial infarction
- antiplatelet therapy
- coronary artery disease
- respiratory failure
- coronary artery bypass grafting
- aortic dissection
- drug induced
- atrial fibrillation
- risk factors
- coronary artery bypass
- extracorporeal membrane oxygenation
- hepatitis b virus